1. Roth DM, Bayona F, Baddam P, Graf D. Craniofacial Development: Neural Crest in Molecular Embryology. Head Neck Pathol. 2021;15(1):1-15. doi: 10.1007/s12105-021-01301-z.
2. Özbayrak S, Ağız Hastalıkları Atlası; Tanı Kriterleri, Ayırıcı Tanı ve Tedavi Yaklaşımları. Quintessence Yayıncılık. İstanbul, P:1, 2003.
3. Müller S. Melanin-associated pigmented lesions of the oral mucosa: presentation, differential diagnosis, and treatment. Dermatol Ther. 2010;23(3):220-229. doi:10.1111/j.1529-8019.2010.01319.x
4. De Giorgi V, Sestini S, Bruscino N, et al. Prevalence and distribution of solitary oral pigmented lesions: a prospective study. J Eur Acad Dermatol Venereol. 2009;23(11):1320-1323. doi:10.1111/j.1468-3083.2009.03186.x
5. Kauzman A, Pavone M, Blanas N, Bradley G. Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations. J Can Dent Assoc. 2004;70(10):682-683.
6. Eisen D. Disorders of pigmentation in the oral cavity. Clin Dermatol. 2000;18(5):579-587. doi:10.1016/s0738-081x(00)00148-6
7. Mallikarjuna K, Gupta S, Shukla S, Chaurasia S. Unusual extensive physiologic melanin pigmentation of the oral cavity: a clinical presentation. J Indian Soc Pedod Prev Dent. 2013;31(2):121-125. doi:10. 4103/0970-4388.115718
8. Müller S. Melanin-associated pigmented lesions of the oral mucosa: presentation, differential diagnosis, and treatment. Dermatol Ther. 2010;23(3):220-229. doi:10.1111/j.1529-8019.2010.01319.x
9. Mallikarjuna K, Gupta S, Shukla S, Chaurasia S. Unusual extensive physiologic melanin pigmentation of the oral cavity: a clinical presentation. J Indian Soc Pedod Prev Dent. 2013;31(2):121-125. doi:10. 4103/0970-4388.115718
10. Nieman LK, Chanco Turner ML. Addison's disease. Clin Dermatol. 2006;24(4):276-280. doi:10.1016/j.clindermatol.2006.04.006
11. Espiard S, McQueen J, Sherlock M, et al. Improved urinary cortisol metabolome in addison disease: a prospective trial of dual-release hydrocortisone. J Clin Endocrinol Metab. 2021;106(3):814-825. doi:10. 1210/clinem/dgaa862
12. Sarkar SB, Sarkar S, Ghosh S, Bandyopadhyay S. Addison's disease. Contemp Clin Dent. 2012;3(4):484-486. doi:10.4103/0976-237X.107450
13. Alawi F. Pigmented lesions of the oral cavity: an update. Dent Clin North Am. 2013;57(4):699-710. doi:10.1016/j.cden.2013.07.006
14. Neville B, Damm D, Allen C, Chi A. Oral and maxillofacial pathology. 4th ed. St. Louis: Elsevier; 2016.
15. Lenane P, Powell FC. Oral pigmentation. J Eur Acad Dermatol Venereol. 2000;14(6):448-465. doi:10.1046/j.1468-3083.2000.00143.x
16. Parker CC, Kynaston H, Cook AD, et al. Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial. The Lancet. 2024; 403(10442):2416-2425. doi:10.1016/S0140-6736(24)00549-X
17. Pereira CM, Coletta RD, Jorge J, Lopes MA. Peutz-Jeghers syndrome in a 14-year-old boy: case report and review of the literature. Int J Paediatr Dent. 2005;15(3):224-228. doi:10.1111/j.1365-263X.2005.00627.x
18. Tacheci I, Kopacova M, Bures J. Peutz-Jeghers syndrome. Curr Opin Gastroenterol. 2021;37(3):245-254. doi:10.1097/MOG.0000000000000718.
19. Eisen D. Disorders of pigmentation in the oral cavity. Clin Dermatol. 2000;18(5):579-587. doi:10.1016/s0738-081x(00)00148-6
20. Mozaffari HR, Rezaei F, Sharifi R, Mirbahari SG. Seven-Year Follow-Up of Peutz-Jeghers Syndrome. Case Rep Dent. 2016;2016:6052181. doi:10. 1155/2016/6052181
21. Günhan Ö. Oral ve Maksillofasiyal Patoloji. istanbul: Quintessence Yayıncılık Tanıtım Paz. ve DıG tic. Ltd. gti; 2015.
22. Palmisano B, Berry C, Boyce A, et al. Fibrous dysplasia/McCune-Albright syndrome: state-of-the-art advances, pathogenesis, and basic/translational research. Orphanet J Rare Dis. 2025;20(1):414. doi:10.1186/s13023-025-03909-8
23. Boyd KP, Korf BR, Theos A. Neurofibromatosis type 1. J Am Acad Dermatol. 2009;61(1):1-16. doi:10.1016/j.jaad.2008.12.051
24. Theos A, Korf BR; American College of Physicians; American Physiological Society. Pathophysiology of neurofibromatosis type 1. Ann Intern Med. 2006;144(11):842-849. doi:10.7326/0003-4819-144-11-200606060-00010
25. Yoshida Y. Neurofibromatosis 1 (von recklinghausen disease). Keio J Med. 2025;74(1):37-41. doi:10.2302/kjm.2023-0013-IR.
26. Gosavi SR, Jain RS, Datarkar A. Prevalence of oral neurofibroma in Central Indian population: a retrospective study of 20 years. J Oral Maxillofac Pathol. 2021;25(1):25-30. doi:10.4103/jomfp.JOMFP_237_20
27. Minakawa M, Wares MA, Nakano K, et al. Measuring and imaging of transcutaneous bilirubin, hemoglobin, and melanin based on diffuse reflectance spectroscopy. J Biomed Opt. 2023;28(10):107001. doi:10.1117/ 1.JBO.28.10.107001
28. Zimmer J, Hansen BM, Peswa L, et al. Noninvasive assessment of bilirubin levels in newborn infants with dark skin pigmentation. Acta Paediatr. 2026. doi:10.1111/apa.70454
29. Daley TD, Armstrong JE. Oral manifestations of gastrointestinal diseases. Can J Gastroenterol. 2007;21(4):241-244. doi:10.1155/2007/952673
30. Güncü GN, Tözüm TF, Cağlayan F. Effects of endogenous sex hormones on the periodontium--review of literature. Aust Dent J. 2005;50(3):138-145. doi:10.1111/j.1834-7819.2005.tb00352.x
31. Kurtzman GM, Horowitz RA, Johnston R, Lanphier L. Oral Biofilm and Gender-Specific Health Considerations. Cureus. 2025;17(8):e91289. doi: 10.7759/cureus.91289
32. Lindhe, J, Karring, T., Lang N.P. Clinical Periodontology and Implant Dentistry, Chapter 6, forth edition, blackwell publishing company. 2003
33. Mascarenhas P, Gapski R, Al-Shammari K, Wang HL. Influence of sex hormones on the periodontium. J Clin Periodontol. 2003;30(8):671-681. doi:10.1034/j.1600-051x.2003.00055.x
34. Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol. 1982;6(6):977-998. doi:10.1016/s0190-9622(82)70083-0
35. Kamalabadi YM, Campbell MK, Zitoun NM, Jessani A. Unfavourable beliefs about oral health and safety of dental care during pregnancy: a systematic review. BMC Oral Health. 2023;23(1):762. doi: 10.1186/s12903-023-03439-4
36. Lee HJ, Ha SJ, Lee SJ, Kim JW. Melanocytic nevus with pregnancy-related changes in size accompanied by apoptosis of nevus cells: a case report. J Am Acad Dermatol. 2000;42(5Pt2):936-938. doi:10.1016/s0190-9622(00)90277-9
37. Övetti, NHC, Mungan HNÖ, Yılmaz BŞ, Bulut FD. Hiperkarotenemi. Cukurova Med J. 2018;43(2):500-501. doi:10.17826/cumj.342841
38. Lomelí-Martínez SM, González-Hernández LA, Ruiz-Anaya AJ, et al. Oral manifestations associated with HIV/AIDS patients. Medicina (Kaunas). 2022;58(9):1214. doi:10.3390/medicina58091214
39. Varadarajan S, Balaji TM, Kumar S N, et al. Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy. Dis Mon. 2021;67(9):101167. doi: 10.1016/j.disamonth.2021.101167
40. Venkateswaran N, Ramos JC, Cohen AK, et al. Spotlight on ocular Kaposi's sarcoma: an update on the presentation, diagnosis, and management options. Expert Rev Ophthalmol. 2021;16(6):477-489. doi:10.1080/17469899.2021.1962294
41. Oleske J, Minnefor A, Cooper R Jr, et al. Immune deficiency syndrome in children. JAMA. 1983;249(17):2345-2349.
42. Valdez IH, Pizzo PA, Atkinson JC. Oral health of pediatric AIDS patients: a hospital-based study. ASDC J Dent Child. 1994;61(2):114-118.
43. Wolk R, Massi D, Trochesset D. Pigmented lesions of the oral mucosa: clinical presentation, histology, and recommendations for management. am J Clin Dermatol. 2025;26(5):761-775. doi:10.1007/s40257-025-00950-y
44. Abati S, Sandri GF, Finotello L, Polizzi E. Differential diagnosis of pigmented lesions in the oral mucosa: a clinical based overview and narrative review. cancers (Basel). 2024;16(13):2487. doi:10.3390/cancers16132487
45. Williams MD. Update from the 4th edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas. Head Neck Pathol. 2017;11(1):110-117. doi:10.1007/s12105-017-0789-y
46. Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015; 14(10):930-951. doi:10.1016/j.autrev.2015.06.005
47. Coventry J, Griffiths G, Scully C, Tonetti M. ABC of oral health: periodontal disease. BMJ. 2000;321(7252):36-39. doi:10.1136/bmj.321. 7252.36
48. Folayan MO. The epidemiology, etiology, and pathophysiology of acute necrotizing ulcerative gingivitis associated with malnutrition. J Contemp Dent Pract. 2004;5(3):28-41.
49. Marucha PT. Acute gingival infections. In: Carranza FA, Newman MG, Takei HH, Klokkevold PR, editors. Clinical periodontology. 10th ed. Philadelphia; WB Saunders comp: 2006. p. 391-397.
50. Atout RN, Todescan S. Managing patients with necrotizing ulcerative gingivitis. J Can Dent Assoc. 2013;79:d46.
51. Gasner NS, Brizuela M, Schure RS. Necrotizing Periodontal Diseases. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2025.
52. Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg. 2008;46(3):198-206. doi:10.1016/j.bjoms.2007.07.201
53. Sakarya U, Gündoğan O, İmre A, Arslan B, Pınar E. Rekürren aftöz stomatitli 112 hastanın demografik ve labaratuvar verileri: retrospektif inceleme. KBB-Forum 2014;13(1).
54. Hamishehkar H, Nokhodchi A, Ghanbarzadeh S, Kouhsoltani M. Triamcinolone acetonide oromucoadhesive paste for treatment of aphthous stomatitis. Adv Pharm Bull. 2015;5(2):277-282. doi:10.15171/apb.2015.038
55. Mancini A, Inchingolo AM, Marinelli G, et al. Topical and systemic therapeutic approaches in the treatment of oral herpes simplex virus infection: a systematic review. Int J Mol Sci. 2025;26(17):8490. doi:10. 3390/ijms26178490
56. Scully C. Clinical practice. Aphthous ulceration. N Engl J Med. 2006; 355(2):165-172. doi:10.1056/NEJMcp054630
57. Çağlayan F, Yılmaz A. B. Rekurrent aftoz stomatitis. Atatürk Üni Diş Hekimliği Fak Derg. 2009;47-54.
58. Slebioda Z, Szponar E, Kowalska A. Recurrent aphthous stomatitis: genetic aspects of etiology. Postepy Dermatol Alergol. 2013;30(2):96-102. doi:10.5114/pdia.2013.34158
59. Faustino ISP, Georgaki M, Santos-Silva AR, Vargas PA, Lopes MA. Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis. Oral Oncol. 2022;125:105710. doi: 10.1016/j.oraloncology.2021.105710.
60. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. doi:10.1038/nrdp.2017.38
61. Popa C, Stelea C, Popa R, Popescu E. Leziuni pigmentare endogene orale i periorale [oral and perioral endogenous pigmented lesions]. Rev Med Chir Soc Med Nat Iasi. 2008;112(4):1054-1060.
62. Moscarella E, Ronchi A, Brancaccio G, et al. Spectrum of blue nevus-like lesions, including blue nevus, pigmented epithelioid melanocytoma, and animal-type melanoma. Clin Dermatol. 2025;43(3):323-333. doi:10. 1016/j.clindermatol.2024.09.003
63. Ciçek Y, Ertaş U. The normal and pathological pigmentation of oral mucous membrane: a review. J Contemp Dent Pract. 2003;4(3):76-86.
64. Buchner A, Merrell PW, Carpenter WM. Relative frequency of solitary melanocytic lesions of the oral mucosa. J Oral Pathol Med. 2004;33(9):550-557. doi:10.1111/j.1600-0714.2004.00238.x
65. Heper AO, Aydıner F, Erol E, Ensari A, Dökmeci F. Blue (mavi) nevüs’ün nadir bir lokalizasyonu ve uterin serviksin pigmente lezyonları: olgu sunumu. KÜ Tıp Fak Derg. 2008;9:29-31.
66. Mortazavi H, Safi Y, Baharvand M, Rahmani S, Jafari S. Peripheral exophytic oral lesions: a clinical decision tree. Int J Dent. 2017; 2017:9193831. doi: 10.1155/2017/9193831
67. Lovas GL, Wysocki GP, Daley TD. The oral blue nevus: histogenetic implications of its ultrastructural features. Oral Surg Oral Med Oral Pathol. 1983;55(2):145-150. doi:10.1016/0030-4220(83)90170-6
68. González-Cámpora R, Galera-Davidson H, Vázquez-Ramírez FJ, Díaz-Cano S. Blue nevus: classical types and new related entities. A differential diagnostic review. Pathol Res Pract. 1994;190(6):627-635. doi:10.1016/S0344-0338(11)80402-4
69. Mooi WJ, Krausz T: Biopsy Pathology of melanocytic disorders. Biopsy Pathology Series, Chapman & Hall Medical. London. 1992:106-135.
70. Schäfer T, Merkl J, Klemm E, Wichmann HE, Ring J; KORA Study Group. The epidemiology of nevi and signs of skin aging in the adult general population: results of the KORA-survey 2000. J Invest Dermatol. 2006;126(7):1490-1496. doi:10.1038/sj.jid.5700269
71. Praetorius C, Sturm RA, Steingrimsson E. Sun-induced freckling: ephelides and solar lentigines. Pigment Cell Melanoma Res. 2014;27(3): 339-350. doi:10.1111/pcmr.12232
72. Cardoso LB, Consalaro A, da Silva Santos PS, da Silva Sampieri MB, Tinoco-Araújo JE. Oral compound nevus. Dermatol Online J. 2014; 20(2):doj_21542.
73. McLean N, Tighiouart M, Muller S. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol. 2008;44(11):1039-1046. doi:10.1016/j.oraloncology.2008.01.014
74. Patrick RJ, Fenske NA, Messina JL. Primary mucosal melanoma. J Am Acad Dermatol. 2007;56(5):828-834. doi:10.1016/j.jaad.2006.06.017
75. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol. 2000;36(2):152-169. doi:10.1016/s1368-8375 (99)00085-8
76. Mogensen M, von Knorring T, Hölmich LR, et al. Modermærkekræft [melanoma]. Ugeskr Laeger. 2025;187(14):V10240698. doi:10.61409/V10240698
77. Hicks MJ, Flaitz CM. Oral mucosal melanoma: epidemiology and pathobiology. Oral Oncol. 2000;36(2):152-169. doi:10.1016/s1368-8375 (99)00085-8
78. Tavares TS, Meirelles DP, de Aguiar MCF, Caldeira PC. Pigmented lesions of the oral mucosa: a cross-sectional study of 458 histopathological specimens. Oral Dis. 2018;24(8):1484-1491. doi:10.1111/odi.12924
79. Gupta G, Williams RE, Mackie RM. The labial melanotic macule: a review of 79 cases. Br J Dermatol. 1997;136(5):772-775.
80. Tavares TS, Meirelles DP, de Aguiar MCF, Caldeira PC. Pigmented lesions of the oral mucosa: a cross-sectional study of 458 histopathological specimens. Oral Dis. 2018;24(8):1484-1491. doi:10.1111/odi.12924
81. Lambertini M, Patrizi A, Ravaioli GM, Dika E. Oral pigmentation in physiologic conditions, post-inflammatory affections and systemic diseases. G Ital Dermatol Venereol. 2018;153(5):666-671. doi:10.23736/S0392-0488.17.05619-X
82. Kauzman A, Pavone M, Blanas N, Bradley G. Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations. J Can Dent Assoc. 2004;70(10):682-683.
83. Hassona Y, Sawair F, Al-Karadsheh O, Scully C. Prevalence and clinical features of pigmented oral lesions. Int J Dermatol. 2016;55(9):1005-1013. doi:10.1111/ijd.13133
84. Holmstrup P, Plemons J, Meyle J. Non-plaque-induced gingival diseases. J Periodontol. 2018;89 Suppl 1:S28-S45. doi:10.1002/JPER.17-0163
85. Hedin CA, Axéll T. Oral melanin pigmentation in 467 Thai and Malaysian people with special emphasis on smoker's melanosis. J Oral Pathol Med. 1991;20(1):8-12. doi:10.1111/j.1600-0714.1991.tb00879.x
86. Müller S. Melanin-associated pigmented lesions of the oral mucosa: presentation, differential diagnosis, and treatment. Dermatol Ther. 2010;23(3):220-229. doi:10.1111/j.1529-8019.2010.01319.x
87. Meleti M, Vescovi P, Mooi WJ, van der Waal I. Pigmented lesions of the oral mucosa and perioral tissues: a flow-chart for the diagnosis and some recommendations for the management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;105(5):606-616. doi:10.1016/j.tripleo. 2007.07.047
88. Livingstone D, Baliah J, Flora J, Sivabalan P. Half and half smoker's melanosis. Br Dent J. 2025;239(6):367-368. doi:10.1038/s41415-025-9213-2
89. Neville BW, Damm DD, Allen CM, Bouquot JE, editörler. Oral ve maksillofasiyal patoloji. 2. baskı Toronto (ON): W.B. Saunders Company; 2002.
90. Cawley EP, Curtis AC. Lentigo senilis. AMA Arch Derm Syphilol. 1950; 62(5):635-641. doi:10.1001/archderm.1950.01530180024005
91. Lodish MB, Stratakis CA. The differential diagnosis of familial lentiginosis syndromes. Fam Cancer. 2011;10(3):481-490. doi:10.1007/s10689-011-9446-x
92. 92. Naidu RM, Joshua E, Saraswathi T, Ranganathan K. Pigmentation of palatal mucosa due to trauma: a case report. J Oral Maxillofac Pathol. 2002;1:34-6.
93. McNamara KK, Kalmar JR. Erythematous and Vascular Oral Mucosal Lesions: A Clinicopathologic Review of Red Entities. Head Neck Pathol. 2019;13(1):4-15. doi:10.1007/s12105-019-01002-8
94. Amirchaghmaghi M, Pakfetrat A, Kiafar B, Zamani T. Dermoscopy of pigmented oral lesions; a research study. Photodiagnosis Photodyn Ther. 2025;52:104524. doi:10.1016/j.pdpdt.2025.104524
95. Lazos JP, Piemonte ED, Panico RL. Oral varix: a review. Gerodontology. 2015;32(2):82-89. doi:10.1111/ger.12074
96. Kauzman A, Pavone M, Blanas N, Bradley G. Pigmented lesions of the oral cavity: review, differential diagnosis, and case presentations. J Can Dent Assoc. 2004;70(10):682-683.
97. Gaeta GM, Satriano RA, Baroni A. Oral pigmented lesions. Clin Dermatol. 2002;20(3):286-288. doi:10.1016/s0738-081x(02)00225-0
98. Holm A, Mulliken JB, Bischoff J. Infantile hemangioma: the common and enigmatic vascular tumor. J Clin Invest. 2024;134(8):e172836. doi: 10.1172/JCI172836
99. Doğan M, Ozgürsoy OB, Muz SE, Gerçeker M, Dursun G. Erişkinlerde larengeal hemanjiyoma yaklaşım: olgu sunumu [Management of laryngeal hemangioma in adults: a case report]. Kulak Burun Bogaz Ihtis Derg. 2010;20(6):314-317.
100. Gaballah AH, Jensen CT, Palmquist S, et al. Angiosarcoma: clinical and imaging features from head to toe. Br J Radiol. 2017;90(1075):20170039. doi:10.1259/bjr.20170039
101. Connor SE, Flis C, Langdon JD. Vascular masses of the head and neck. Clin Radiol. 2005;60(8):856-868. doi:10.1016/j.crad.2005.04.002
102. Fanburg-Smith JC, Furlong MA, Childers EL. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases. Mod Pathol. 2003; 16(3):263-271. doi:10.1097/01.MP.0000056986.08999.FD.
103. Gatti RA. Ataxia-telangiectasia. Dermatol Clin. 1995;13(1):1-6.
104. Marx RE, Stern D. Oral and maxillofacial pathology: a rationale for diagnosis and treatment. Quintessence. 2012.
105. Sreeja C, Ramakrishnan K, Vijayalakshmi D, Devi M, Aesha I, Vijayabanu B. Oral pigmentation: a review. J Pharm Bioallied Sci. 2015; 7(Suppl 2):S403-S408. doi:10.4103/0975-7406.163471
106. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2(4):253-262. doi:10.2165/ 00128071-200102040-00006
107. Alawi F. Pigmented lesions of the oral cavity: an update. Dent Clin North Am. 2013;57(4):699-710. doi:10.1016/j.cden.2013.07.006
108. Mårs U, Larsson BS. Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res. 1999;12(4):266-274. doi:10.1111/j.1600-0749.1999.tb00760.x
109. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol. 2001;2(4):253-262. doi:10.2165/ 00128071-200102040-00006
110. Gökdemir G. Oral Mukozanın Benign Pigmente Lezyonları. Archives of the Turkish Dermatology. Venerology/Turkderm. 2012;46(2):66-71.
111. Camayo TV, Lee VR, Zhou XA. Drug-induced pigmentation. In: StatPearls. Treasure Island (FL). StatPearls 2025.
112. Buchner A, Hansen LS. Amalgam pigmentation (amalgam tattoo) of the oral mucosa. A clinicopathologic study of 268 cases. Oral Surg Oral Med Oral Pathol. 1980;49(2):139-147. doi:10.1016/0030-4220(80)90306-0
113. Sasaki R, Taneda S, Okamoto T. Gingival amalgam tattoo. CMAJ. 2023; 195(32):E1083-E1084. doi:10.1503/cmaj.230584.
114. Thumbigere-Math V, Johnson DK. Treatment of amalgam tattoo with a subepithelial connective tissue graft and acellular dermal matrix. J Int Acad Periodontol. 2014;16(2):50-54.
115. Allen CM, Camisa C: Oral disease. Dermatology. Ed. Bolognia JL, Jorizzo JL,Rapini RP. 2. Baskı, Londra, Elsevier, 2008;1038.
116. Gaeta GM, Satriano RA, Baroni A. Oral pigmented lesions. Clin Dermatol. 2002;20(3):286-288. doi:10.1016/s0738-081x(02)00225-0
117. Abati S, Sandri GF, Finotello L, Polizzi E. Differential diagnosis of pigmented lesions in the oral mucosa: a clinical based overview and narrative review. Cancers (Basel). 2024;16(13):2487. doi:10.3390/cancers16132487
118. Bailleul-Forestier I, Monod-Broca J, Benkerrou M, Mora F, Picard B. Generalized periodontitis associated with Chédiak-Higashi syndrome. J Periodontol. 2008;79(7):1263-1270. doi:10.1902/jop.2008.070440
119. Grønskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43. doi:10.1186/1750-1172-2-43
120. Bailleul-Forestier I, Monod-Broca J, Benkerrou M, Mora F, Picard B. Generalized periodontitis associated with Chédiak-Higashi syndrome. J Periodontol. 2008;79(7):1263-1270. doi:10.1902/jop.2008.070440
121. Murthy V, V Y, Thomas S, Nair P. Prosthodontic management of an albinism patient-dental implications and management. BMJ Case Rep. 2013;2013:bcr2012008004. doi:10.1136/bcr-2012-008004
122. Moretti S. Giannotti B, editör. Vitiligo.
123. Lawoyin D, Brown R, Reid E, Sam F, Obayomi T. Concurrent presentation of cutaneous and oral soft tissue vitiligo: a case report and literature review. Int J of Dent Sci. 2007; 5:56-60.
124. Haulrig MB, Idorn L, Skov L. Vitiligo [Vitiligo]. Ugeskr Laeger. 2025; 187(14):V10240662. doi:10.61409/V10240662
125. Nagarajan A, Masthan MK, Sankar LS, Narayanasamy AB, Elumalai R. Oral manifestations of vitiligo. Indian J Dermatol. 2015;60(1):103. doi: 10.4103/0019-5154.147844